Philip Liang is Director of Vicarious Surgical Inc.. Currently has a direct ownership of 1.22 Million shares of RBOT, which is worth approximately $16.8 Million. The most recent transaction as insider was on Feb 06, 2023, when has been sold 26,811 shares (Class A Common Stock) at a price of $3.05 per share, resulting in proceeds of $81,773. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.22M
0% 3M change
0% 12M change
Total Value Held $16.8 Million

Philip Liang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2023
BUY
Open market or private purchase
$81,773 $3.05 p/Share
26,811 Added 2.15%
1,218,338 Class A Common Stock
Dec 31 2022
BUY
Grant, award, or other acquisition
-
6,207 Added 0.52%
1,191,527 Class A Common Stock
Nov 10 2022
SELL
Open market or private sale
$53,850 $3.59 p/Share
15,000 Reduced 1.25%
1,185,320 Class A Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
3,743 Added 0.31%
1,200,320 Class A Common Stock
Sep 16 2022
SELL
Open market or private sale
$47,625 $3.81 p/Share
12,500 Reduced 1.03%
1,196,577 Class A Common Stock
Sep 15 2022
SELL
Open market or private sale
$24,111 $4.23 p/Share
5,700 Reduced 0.47%
1,209,077 Class A Common Stock
Sep 14 2022
SELL
Open market or private sale
$32,528 $4.28 p/Share
7,600 Reduced 0.62%
1,214,777 Class A Common Stock
Sep 12 2022
SELL
Open market or private sale
$53,505 $4.48 p/Share
11,943 Reduced 0.97%
1,222,377 Class A Common Stock
Sep 09 2022
SELL
Open market or private sale
$35,693 $4.43 p/Share
8,057 Reduced 0.65%
1,234,320 Class A Common Stock
Aug 11 2022
SELL
Open market or private sale
$70,235 $4.36 p/Share
16,109 Reduced 1.28%
1,242,377 Class A Common Stock
Aug 10 2022
SELL
Open market or private sale
$16,498 $4.24 p/Share
3,891 Reduced 0.31%
1,258,486 Class A Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
-
4,264 Added 0.34%
1,262,377 Class A Common Stock
Jun 06 2022
SELL
Open market or private sale
$91,200 $4.56 p/Share
20,000 Reduced 1.56%
1,258,113 Class A Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
38,031 Added 2.89%
1,278,113 Class A Common Stock
May 31 2022
SELL
Open market or private sale
$118,720 $4.24 p/Share
28,000 Reduced 2.21%
1,240,082 Class A Common Stock
May 13 2022
SELL
Open market or private sale
$114,464 $3.92 p/Share
29,200 Reduced 2.25%
1,268,082 Class A Common Stock
May 12 2022
SELL
Open market or private sale
$54,150 $3.61 p/Share
15,000 Reduced 1.14%
1,297,282 Class A Common Stock
Apr 04 2022
BUY
Other acquisition or disposition
-
1,007,100 Added 43.49%
1,308,799 Class A Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
2,283 Added 0.17%
1,312,282 Class A Common Stock
Mar 17 2022
BUY
Grant, award, or other acquisition
-
265,990 Added 46.85%
301,699 Class A Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
-
1,200 Added 0.09%
1,309,999 Class A Common Stock
Nov 23 2021
BUY
Grant, award, or other acquisition
-
35,709 Added 78.77%
9,624 Class A Common Stock
PL

Philip Liang

Director
Waltham, MA

Track Institutional and Insider Activities on RBOT

Follow Vicarious Surgical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RBOT shares.

Notify only if

Insider Trading

Get notified when an Vicarious Surgical Inc. insider buys or sells RBOT shares.

Notify only if

News

Receive news related to Vicarious Surgical Inc.

Track Activities on RBOT